CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...
Phase 3
San Antonio, Texas, United States and 32 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
San Antonio, Texas, United States and 295 other locations
safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney...
Phase 1
San Antonio, Texas, United States and 11 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
San Antonio, Texas, United States and 100 other locations
compared with dapagliflozin alone on patients with chronic kidney disease (CKD) and albuminuria. This study will evaluate the effec...
Phase 2
San Antonio, Texas, United States and 116 other locations
CRP-lowering effect of quarterly and monthly subcutaneous administration of TOUR006 (also known as pacibekitug) in participants with chronic kidney...
Phase 2
San Antonio, Texas, United States and 48 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
San Antonio, Texas, United States and 338 other locations
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys...
Phase 2
San Antonio, Texas, United States and 167 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
San Antonio, Texas, United States and 84 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
San Antonio, Texas, United States and 297 other locations
Clinical trials
Research sites
Resources
Legal